國立高雄大學圖資館 |

登入

回首頁

Respiratory delivery of biologics, nucleic acids, and vaccines

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Respiratory delivery of biologics, nucleic acids, and vaccinesedited by Jenny Lam, Philip Chi Lip Kwok.
其他作者:	Lam, Jenny.
出版者:	Cham :Springer International Publishing :2023.
面頁冊數:	x, 216 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Drug delivery systems.
電子資源:	https://doi.org/10.1007/978-3-031-47567-2
ISBN:	9783031475672$q(electronic bk.)

Respiratory delivery of biologics, nucleic acids, and vaccines
Respiratory delivery of biologics, nucleic acids, and vaccines[electronic resource] /edited by Jenny Lam, Philip Chi Lip Kwok. - Cham :Springer International Publishing :2023. - x, 216 p. :ill. (some col.), digital ;24 cm. - AAPS introductions in the pharmaceutical sciences,v. 82522-8358 ;. - AAPS introductions in the pharmaceutical sciences ;v. 9..

Chapter 1: Design strategies of dry powders for pulmonary delivery of pharmaceutical peptides -- Chapter 2. Pulmonary delivery of antibody for the treatment of respiratory diseases -- Chapter 3: Dry powder formulation of monoclonal antibodies for pulmonary delivery -- Chapter 4: Antimicrobial peptides and proteins for inhalation -- Chapter 5: Pulmonary delivery of nucleic acids -- Chapter 6: Intranasal and inhaled vaccines -- Chapter 7: Respiratory delivery of probiotics to improve lung health -- Chapter 8: Respiratory delivery of bacteriophages for the treatment of lung infections -- Chapter 9: Pharmacokinetics of inhaled medications - what do we know about biological macromolecules?.

Therapeutic macromolecules and biologics have gained increasing importance in the last decade. Pulmonary and intranasal delivery of these therapeutic modalities, which have poor oral bioavailability, could constitute an attractive, non-invasive alternative to parenteral delivery. They can be considered for either topical use for treating diseases affecting the airways or for systemic use for treating a variety of other diseases. Therefore, this book is a readable, thoughtful, and useful guide on the latest research developments and the best options that people involved with pulmonary and intranasal route of administration and biologically active agents can bring to their practices. Furthermore, it explores the underlying scientific rationale for the strategies applied to overcome drug delivery challenges and provides insights to inspire further research in this growing area.

ISBN: 9783031475672$q(electronic bk.)

Standard No.: 10.1007/978-3-031-47567-2doiSubjects--Topical Terms:

196465
Drug delivery systems.

LC Class. No.: RS199.5

Dewey Class. No.: 615.6

Respiratory delivery of biologics, nucleic acids, and vaccines
LDR:02661nmm a2200337 a 4500 001 654881
003 DE-He213
005 20240119143630.0
006 m d
007 cr nn 008maaau
008 240524s2023 sz s 0 eng d
020 $a 9783031475672$q(electronic bk.)
020 $a 9783031475665$q(paper)
024 7 $a 10.1007/978-3-031-47567-2 $2 doi
035 $a 978-3-031-47567-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RS199.5
072 7 $a PSB $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a PNB $2 thema
082 0 4 $a 615.6 $2 23
090 $a RS199.5 $b .R434 2023
245 0 0 $a Respiratory delivery of biologics, nucleic acids, and vaccines $h [electronic resource] / $c edited by Jenny Lam, Philip Chi Lip Kwok.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a x, 216 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a AAPS introductions in the pharmaceutical sciences, $x 2522-8358 ; $v v. 8
505 0 $a Chapter 1: Design strategies of dry powders for pulmonary delivery of pharmaceutical peptides -- Chapter 2. Pulmonary delivery of antibody for the treatment of respiratory diseases -- Chapter 3: Dry powder formulation of monoclonal antibodies for pulmonary delivery -- Chapter 4: Antimicrobial peptides and proteins for inhalation -- Chapter 5: Pulmonary delivery of nucleic acids -- Chapter 6: Intranasal and inhaled vaccines -- Chapter 7: Respiratory delivery of probiotics to improve lung health -- Chapter 8: Respiratory delivery of bacteriophages for the treatment of lung infections -- Chapter 9: Pharmacokinetics of inhaled medications - what do we know about biological macromolecules?.
520 $a Therapeutic macromolecules and biologics have gained increasing importance in the last decade. Pulmonary and intranasal delivery of these therapeutic modalities, which have poor oral bioavailability, could constitute an attractive, non-invasive alternative to parenteral delivery. They can be considered for either topical use for treating diseases affecting the airways or for systemic use for treating a variety of other diseases. Therefore, this book is a readable, thoughtful, and useful guide on the latest research developments and the best options that people involved with pulmonary and intranasal route of administration and biologically active agents can bring to their practices. Furthermore, it explores the underlying scientific rationale for the strategies applied to overcome drug delivery challenges and provides insights to inspire further research in this growing area.
650 0 $a Drug delivery systems. $3 196465
650 0 $a Lungs $x Diseases $x Chemotherapy. $3 944841
650 0 $a Biologicals. $3 667671
650 0 $a Inhalers. $3 676673
650 1 4 $a Pharmaceutics. $3 913065
650 2 4 $a Drug Delivery. $3 911847
650 2 4 $a Biologics. $3 943929
650 2 4 $a Biomaterials-Vaccines. $3 929055
650 2 4 $a Structure-Based Drug Design. $3 913066
650 2 4 $a Pharmacology. $3 218135
700 1 $a Lam, Jenny. $3 965936
700 1 $a Kwok, Philip Chi Lip. $3 817887
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a AAPS introductions in the pharmaceutical sciences ; $v v. 9. $3 943878
856 4 0 $u https://doi.org/10.1007/978-3-031-47567-2
950 $a Medicine (SpringerNature-11650)